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Abstract - The use of medicinal plants is becoming increasingly appreciated in suppressing cancer growth and cancer 
prevention. In this study the antiproliferative effects of the water extracts of previously obtained ethanolic dry extracts of 
three different medicinal plants (Camellia sinensis, Frangula alnus from two different places and Rosmarinus officinalis) 
using cell lines derived from human cervix adenocarcinoma (Hela cells) were investigated. The extract of Camellia sinensis 
exhibited significant cytotoxic effect against Hela cells (IC50 40.88 μg/ml). Screening in Hela cells revealed a moderate 
cytotoxic effect (IC50 80.26μg/ml) of the extract of Rosmarinus officinalis, a mild cytotoxic effect (IC50 148.05 μg/ml) of the 
extract of Frangula alnus (originating in Bosnia), and the extract of Frangula alnus (originating in Serbia) did not show 
active cytotoxicity (IC50 > 200 μg/ml). The best antiproliferative properties are those of Camellia sinensis, followed by Ros-
marinus officinalis, and the least effective was Frangula alnus. As regards geographic origin, the Frangula alnus from Bosnia 
possessed better antiproliferative effects than Frangula alnus from Serbia. 
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InTrODuCTIOn
Cancer is one of the major causes of death in devel-
oped countries together with cardiac and cerebrovas-
cular diseases (WHO, 1998). Cancer can be clinically 
treated by surgery, radiotherapy and chemotherapy. 
After the surgical ablation of progressive cancer, how-
ever, metastasized tumor cells continue to progress 
and this is one of the causes making cancer treatment 
difficult (Fidler and kripke, 1977). Ionizing radiation 
and most anticancer drugs damage DnA, suppress 
DnA replication, killing rapidly growing tumor cells, 
However, at the same time these treatments affect 
normal  cells,  causing  serious  adverse  effects,  such 
as inhibition of bone marrow functioning nausea, 
vomiting  and  alopecia  (kligerman,  1973;  Medical 
economics, 1998). Thus, more effective anticancer 
drugs with high selectivity against only malignant 
cells and with the ability to repress tumor metastasis 
are desired. As candidates for such drugs, cytotoxic, 
antitumor or anticancer natural products have been 
sought, and plant components such as Vinca alka-
loids, taxoids, etoposide and irinotecan are now used 
in clinical treatments (Medical economics, 1998).
Since ancient times, plants have been the source 
of medicines for the treatment of diseases. regardless 
of the availability of a wealth of synthetic drugs, plants 886 DeSAnkA CenIC-MIlOSevIC eT Al.
remain an integral part of the health care in different 
countries, especially the developing countries. In the 
late 1990s, the WHO stated that a large percentage of 
the world’s population depends on plant-based ther-
apies to cover the needs of primary health care (Diks-
hit et al., 2004). Moreover, towards the end of the 20th 
century, plant-based OTC products, nutraceuticals 
and  food  supplements  comprising  complementary 
and alternative therapies have gained a big share in 
the drug market in developed countries.
Over  the  past  decade,  herbal  medicines  have 
been accepted universally, and they have an impact 
on both world health and international trade. Hence, 
medicinal  plants  continue  to  play  an  important 
role in the healthcare system of a large number of 
the world’s population (Akerele, 1988). Traditional 
medicine is widely used in Serbia as well. Medicinal 
plants possess immunomodulatory (Agrawala et al., 
2001; Pandey and Madhuri, 2006) and antioxidant 
properties that are related to certain aspects of an-
ticancer activities. The use of medicinal plants is be-
coming increasingly appreciated in suppressing can-
cer growth (Waladkhani and Clemens, 1998; Orsolic 
and  Basic,  2003)  and  potential  cancer  prevention 
(Pan and Ho, 2008).
Camellia  sinensis  (Camellia  sinensis),  Frangula 
alnus (Rhamnus frangula) and Rosmarinus officinalis 
(rosemary) have been widely used and well-docu-
mented medicinal plants for centuries (Weiss, 1988; 
Hansel and Sticher, 2002). However, the anticancer 
properties of Camellia sinensis and Frangula alnus 
have not been fully investigated and proven, while 
there are some data about anticarcinogenic proper-
ties of Rosmarinus officinalis (Teuscher, 2005). In this 
study, we investigated the antiproliferative properties 
of extracts of Thea viridis, Frangula alnus from two 
different places and Rosmarinus officinalis, using cell 
lines derived from human cervix adenocarcinoma.
MATerIAlS AnD MeTHODS
Plant material
Camellia  sinensis is a medicinal plant from India, 
Frangula alnus is from Bosnia, Frangula alnus from 
Serbia, Rosmarinus officinalis is a free-growing plant 
from the Mediterranean. 
Preparation of extracts
extraction was done in a percolator using 70% etha-
nol. low-pressure evaporation of the extract was done 
following extraction. A 2 l glass percolator was first 
lined with some cotton wool, and subsequently filled 
with the desired amount of precut and sifted (0.75 
sift) plant which was then covered with 70% ethanol. 
When the extract started flowing through the faucet 
on the percolator the faucet was then closed and the 
content left to macerate for at least 16 h. Following 
maceration, the extract was poured out of the per-
colator at a speed of 2 liters per hour. The amount of 
the poured extract was six times the volume of the 
starting material (1:6 extract). The extract was then 
stored for the next 3 to 5 days, filtered through a se-
ries of Whatman filters and finally passed through a 
0.22 μm filter (Millipore, Billerica, MA). The extract 
was evaporated in a rotational vacuum evaporator 
until a dry powder was obtained. The temperature in 
the evaporator was kept below 65oC under a pressure 
of 15-25 mbar.
Cell lines
Human cervix adenocarcinoma Hela cells were ob-
tained from the American Type Culture Collection 
(ATCC) (Manassas, vA, uSA). The Hela cells were 
maintained in the recommended nutrition medium: 
rPMI  1640  medium  supplemented  with  100  g/l 
heat-inactivated (56°C) foetal bovine serum (FBS), 
3 mmol/l, l-glutamine, 100 g/ml streptomycin, 100 
Iu/ml penicillin and 25 mmol/l 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic  acid  (HePeS)  and  ad-
justed to pH 7.2 with bicarbonate solution. The cells 
were grown in a humidified atmosphere of 5% CO2 
in air at 37°C.
Treatment of cell line
In the order to obtain water extracts, stock solutions 
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extracts (e1), were resuspended in physiological sa-
line and put in the dark at room temperature for 24 
h; they were shaken for 3 h. These suspensions were 
filtered through 0.22 μm and the obtained solutions 
were diluted in nutrient medium to the various work-
ing concentrations. neoplastic Hela (2000 cells per 
well) cells were seeded into 96-well microtiter plates; 
24 h later, after cell adherence, five different doubly 
diluted  concentrations  of  the  investigated  extracts 
were added to the wells. Because the original extracts 
were not totally dissolved in physiological saline, the 
final concentrations of investigated extracts applied 
to target cells were less than 12.5, 25, 50, 100 and 200 
μg/ml. 
Determination of cell survival
The effect of extracts on target cell survival was deter-
mined by the microculture tetrazolium test (MTT) 
according  to  Mosmann  (1983)  with  modification 
by Ohno and Abe (1991), 72 h after addition of the 
compounds, as described earlier. Briefly, 20 μl of 
MTT solution (5 mg/ml phosphate-buffered saline) 
was added to each well. Samples were incubated for 
a further 4 h under the same conditions. Then, 100 
μl of 100 g/l sodium dodecyl sulfate was added to 
dissolve formazan, the product from the conversion 
of MTT dye by viable cells. The number of viable 
cells in each well was proportional to the intensity of 
the absorbance of light, which was read in an elISA 
plate reader (colorimeter) at 570 nm. The absorbance 
(A) at 570 nm was measured 24 h later. To determine 
cell survival (%), the A of a sample with cells grown 
in the presence of various concentrations of the in-
vestigated extracts was divided by the control optical 
density (the A of control cells grown only in nutrient 
medium) and multiplied by 100. It was implied that 
the A of the blank was always subtracted from the 
A of the corresponding sample with target cells. IC50 
was defined as the concentration of an agent that in-
hibits cell survival by 50% compared with a vehicle-
treated control. All IC50’s were reported as a mean of 
two measurements, each done in triplicate.
IC50 were established from dose-dependent data 
using Graphpad Prism ver 3.0 software.
reSulTS
In vitro cytotoxic activity
The cytotoxic action of Camellia sinensis, Frangula 
alnus (A), Frangula alnus (B) and Rosmarinus offici-
nalis extracts was tested against Hela cells. The cyto-
toxicity (IC50 values in μg/ml) of the extracts against 
the tested cancer cells are summarized in Table 1. 
Fig. 1 depicts the cytotoxic curves from the MTT 
assay showing the survival of Hela cells grown for 
72 h in the presence of increasing concentrations of 
extracts.
The extract of Camellia sinensis exhibited a sig-
nificant cytotoxic effect against Hela cells (IC50 40.88 
μg/ml). The extract of Rosmarinus officinalis revealed 
a moderate cytotoxic effect screened against Hela 
cells (IC50 80.26 μg/ml), the extracts of Frangula alnus 
(A) displayed some mild cytotoxic effect (IC50 148.05 
μg/ml), and the extract of Frangula alnus (B) did not 
show active cytotoxic activity against the Hela cell 
lines (IC50 > 200 μg/ml).
Light microscopy
The cytotoxic effect of extracts observed by light mi-
croscopy (Carl Zeiss inverted microscopy, with total 
magnification 630), at concentrations of 200 μg/ml 
for Hela cells during 72 h of culturing is illustrated 
in Fig. 2. Figs. 2B, 2C, 2e show significant morpho-
logical changes that occurred during 72 h at different 
stages of cell death. The extracts damaged the integ-
rity of the cytoplasmic membrane. In addition, in ac-
cordance with the results of the MTT test, the Hela 
cells treated for 72 h with Frangula alnus (B) grew 
similar the control cells (Fig. 2 D).
DISCuSSIOn
We examined the antiproliferative effects of water ex-
tracts of previously obtained ethanolic dry extracts 
of three different medicinal plants (Camellia sinensis, 
Frangula alnus extract (A) from Bosnia and extract 
(B) from Serbia and Rosmarinus officinalis) on Hela 
cells.888 DeSAnkA CenIC-MIlOSevIC eT Al.
Camellia sinensis (Camellia sinensis) is a species 
of plant whose leaves are used to produce Chinese 
and Indian teas. It is of the genus Camellia, a genus 
of flowering plants in the family Theaceae. The leaves 
have been used in traditional Chinese medicine and 
other medical systems to treat asthma (functioning as 
a bronchodilator), angina pectoris, peripheral vascu-
lar disease and coronary artery disease. Tea extracts 
have become a field of interest, due to their notional 
antibacterial activity. The preservation of processed 
organic food and the treatment of persistent bacte-
rial  infections  are  particularly  being  investigated. 
Green tea leaves and extracts have shown to be effec-
tive against bacteria responsible for halitosis (Ming, 
1992; Golender, 2003). Our results showed that Ca-
mellia sinensis at a concentration of around 40 µg/ml 
(40.88 ± 1.53) inhibited Hela cell survival by 50% 
compared with a vehicle-treated control. Photomet-
ric determination of phenols by showed the presence 
of 24% phenols in the extract of Camellia sinensis.
Frangula alnus (Rhamnus frangula) is a tall de-
ciduous shrub in the family Rhamnaceae. Bark for 
medicinal use is dried and stored for a year before 
use, as fresh bark is violently purgative; even dried 
bark can be dangerous if taken in excess (rushforth, 
1999). There are no data on the antiproliferative ef-
fects of Frangula alnus. According to the results of 
this study, Frangula alnus extract (A) in a concen-
tration of around 148 µg/ml (148.05 ± 8.61) and ex-
tract (B) in concentration of more than 200 µg/ml 
inhibit Hela cell survival by 50 % compared with a 
vehicle-treated control. Photometric determination 
of glucofrangulin by spectrophotometry showed that 
percent is 18.80% in the extract of Frangula alnus (A) 
and 14.65 % in the extract of Frangula alnus (B). The 
concentration of glucofrangulin is higher in Frangula 
alnus (A) (18.80 %) than in Frangula alnus (B) (14.65 
%), which is in correlation with their antiprolifera-
tive effects. 
Rosmarinus officinalis (rosemary) is a member 
of the mint family Lamiaceae. rosemary may have 
some anticarcinogenic properties. A study where a 
powdered form of rosemary was given to rats in a 
measured amount for two weeks showed a reduc-
Fig. 1. representative graph of Hela cells survival after 72 h cell growth in the presence of increasing concentrations of investigated 
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Fig. 2. light microscopy of Hela cells cultured with or without the 200 µg/ml of extracts: A) control; B) Camellia sinensis; C) Frangula 
alnus (A); D) Frangula alnus (B) and e) Rosmarinus officinalis as described in Materials and Methods and photographed 72 h after ad-
dition of drugs (Magnification 12.5X, 1.6X, 6.3/0.2). 890 DeSAnkA CenIC-MIlOSevIC eT Al.
tion in the binding of a certain carcinogen by 76 %, 
and it greatly reduced the formation of mammary 
tumors (Teuscher, 2005). The results of a study sug-
gest that carnosic acid, found in rosemary, may pro-
tect the brain from free radicals, lowering the risk 
of strokes and neurodegenerative diseases, and is 
anti-inflammatory (Mengoni et al., 2011). Carnosol 
is also a promising cancer chemoprevention and an-
ticancer agent (johnson, 2011). The results of this 
study showed that Rosmarinus officinalis in a con-
centration of around 80 µg/ml (80.26 ± 1.06) inhib-
its Hela cell survival by 50% compared with a vehi-
cle-treated control. rosemary contains a number of 
potentially biologically active compounds, includ-
ing antioxidants carnosic acid and rosmarinic acid. 
Other bioactive compounds include camphor (up 
to 20% in dry rosemary leaves), caffeic acid, ursolic 
acid, betulinic acid, rosmaridiphenol and rosmanol. 
rosemary antioxidant levels are closely related to 
soil  moisture  content  (national  non-Food  Crops 
Centre, 2006). 
Medicinal plants maintain the health and vital-
ity of individuals, and have the potential to improve 
various diseases, including cancer. This study inves-
tigates the antiproliferative effects of extracts of Ca-
mellia sinensis, Frangula alnus (A – from Bosnia and 
B – from Serbia) and Rosmarinus officinalis on Hela 
cells. Obtained results show that the best antiprolif-
erative properties are those of Camellia sinensis, then 
Rosmarinus officinalis, and lastly Frangula alnus. De-
pending  on  the  geographic  origin, Frangula alnus 
from Bosnia possessed better antiproliferative effects 
than Frangula alnus from Serbia. 
An important goal of our future studies will be 
to investigate the antiproliferative effects and anti-
cancer properties of other medicinal plants and royal 
jelly which is used in Serbian folk medicine for dif-
ferent purposes. 
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